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Nesprin-2-dependent ERK1/2 compartmentalisation
regulates the DNA damage response in vascular
smooth muscle cell ageing
DT Warren*,1, T Tajsic2, LJ Porter1, RM Minaisah1, A Cobb1, A Jacob1, D Rajgor1, QP Zhang1 and CM Shanahan*,1
Prelamin A accumulation and persistent DNA damage response (DDR) are hallmarks of vascular smooth muscle cell (VSMC)
ageing and dysfunction. Although prelamin A is proposed to interfere with DNA repair, our understanding of the crosstalk
between prelamin A and the repair process remains limited. The extracellular signal-regulated kinases 1 and 2 (ERK1/2) have
emerged as key players in the DDR and are known to enhance ataxia telangiectasia-mutated protein (ATM) activity at DNA
lesions, and in this study, we identified a novel relationship between prelamin A accumulation and ERK1/2 nuclear
compartmentalisation during VSMC ageing. We show both prelamin A accumulation and increased DNA damage occur
concomitantly, before VSMC replicative senescence, and induce the localisation of ERK1/2 to promyelocytic leukaemia protein
nuclear bodies (PML NBs) at the sites of DNA damage via nesprin-2 and lamin A interactions. Importantly, VSMCs treated with
DNA damaging agents also displayed prelamin A accumulation and ERK compartmentalisation at PML NBs, suggesting that
prelamin A and nesprin-2 are novel components of the DDR. In support of this, disruption of ERK compartmentalisation at PML
NBs, by either depletion of nesprin-2 or lamins A/C, resulted in the loss of ATM from DNA lesions. However, ATM signalling
and DNA repair remained intact after lamins A/C depletion, whereas nesprin-2 disruption ablated downstream Chk2 activation
and induced genomic instability. We conclude that lamins A/C and PML act as scaffolds to organise DNA-repair foci and
compartmentalise nesprin-2/ERK signalling. However, nesprin-2/ERK signalling fidelity, but not their compartmentalisation at
PML NBs, is essential for efficient DDR in VSMCs.
Cell Death and Differentiation (2015) 22, 1540–1550; doi:10.1038/cdd.2015.12; published online 6 March 2015
DNA damage is a major driving force during cellular ageing,
and it has been implicated in hastening the development of
cardiovascular diseases, including atherosclerosis where the
accumulation of senescent cells has been shown to accel-
erate disease.1 Normally, DNA damage is efficiently repaired
by the DNA damage response (DDR), a complex signalling
cascade of proteins that include sensors (NBS1/MRE11),
transducers (ataxia telangiectasia-mutated protein (ATM)/
ataxia telangiectasia- and Rad3-related protein (ATR)) and
effectors (p53/p21). However, if damage is overwhelming or
repair is inefficient, the accumulation of unrepaired DNA
damage leads to persistent DNA damage signalling and
premature senescence.2 Recently, the nuclear lamina has
been implicated in the DDR, and its disruption is associated
with accelerated cardiovascular ageing.3
The nuclear lamina is composed of A-type (lamins A/C) and
B-type (lamins B1/B2) lamins that underlie the nuclear
envelope (NE) and extend throughout the nucleoplasm4 to
form a scaffold that is essential for the compartmentalisation
and the integrity of nuclear signalling.4 The pathological
accumulation of lamin A precursors such as prelamin A or
progerin causes Hutchinson Gilford Progeria Syndrome
(HGPS), a disease of accelerated ageing where patients
develop severe early-onset arteriosclerosis characterised by
vascular smooth muscle cell (VSMC) attrition.4 During the
DDR, lamin A interacts with Ku70 and γH2AX, and forms a
framework that is essential for the positional stability of repair
foci.5,6 Prelamin A accumulation interferes with DNA-repair
processes and has been shown to delay the recruitment of
DNA-repair proteins such as 53BP1 to double strand breaks
(DSBs)7 and cause mislocalisation of DNA PKcs.
8 Fibroblasts
and induced pluripotent stem (iPS) cells derived from HGPS
patients show persistent DNA damage signalling and pre-
mature senescence.8 Importantly, aged VSMCs, both in vitro
and in vivo, also accumulate prelamin A and activate
persistent DDR, suggesting a key role for the nuclear lamina
in vascular ageing.2
The nesprin family of spectrin-repeat (SR) proteinswere first
identified as NE lamin A-binding proteins. However, both
nesprin-1 and nesprin-2 show extensive alternate splicing,
and variants have been shown to localise to multiple
nuclear and cytoplasmic compartments.9 One such variant,
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nesprin-2βΔKASH1, retains a lamin A-binding region and
localises to promyelocytic leukaemia protein nuclear bodies
(PML NBs) in VSMCs.10 Previously, we demonstrated that
nesprin-2βΔKASH1 scaffolds extracellular signal-regulated
kinases 1 and 2 (ERK1/2) at PML NBs and acts to
regulate nuclear ERK1/2 activity and downstream VSMC
proliferation.10 Importantly, both ERK and PML NBs have also
been implicated in the DDR; PML and ERK1/2 localise at DNA
lesions where ERK1/2 enhance ATM- and ATR-mediated
repair.11–13 In addition, PML and ERK1/2 are essential for
regulating the cell cycle in response to DNA damage; PML
forms nucleolar cap structures that sequester MDM2 and
activate DNA damage-mediated p53 signalling, while ERK1/2
are essential for efficient G2/M checkpoint activation.14–16
Similar to nesprin-2, PML and ERK1/2 have also been shown
to associate with the nuclear lamina suggesting that the
nuclear lamina, potentially via nesprin-2βΔKASH1, may
regulate ERK compartmentalisation during the DDR.17,18
In this study, we identify a novel signalling complex that
regulates compartmentalisation of ERK1/2 during the DDR in
VSMCs. We show that the nuclear lamina tethers PML NBs
and spatially organises nuclear signalling events. Disruption of
this organisation results in ATM mislocalisation from DNA-
repair foci and impairs downstream DNA-repair signalling,
ultimately leading to genomic instability.
Results
Prelamin A accumulation, persistent DDR and increased
ERK1/2 compartmentalisation at PML NBs are asso-
ciated with VSMC ageing. To model ageing, VSMCs were
serially passaged in vitro, which identified three distinct
phases of cell growth. Early-passage cells proliferated with a
population-doubling time (PDT) of 2–5 days showed no
evidence of DNA damage, measured by formation of γH2AX
and 53BP1 foci, and did not accumulate prelamin A (Figures
1a–g and Supplementary Figures 1 and 2). After a number of
further passages dependent on cell isolate, VSMCs reduced
their growth rate (PDT of 6–8 days) and entered presenes-
cence, characterised by increased prelamin A levels and
persistent DNA damage signalling marked by increased
γH2AX and 53BP1 foci (Figures 1a–g and Supplementary
Figures 1 and 2). Western blotting revealed that decreased
FACE1 levels were associated with prelamin A accumulation
in presenescent VSMCs (Figure 1e). However, these cells
did not show increased senescence-associated β-galacto-
sidase activity (SA-β-gal; Figure 1b and Supplementary
Figure 1). This contrasted with senescent VSMCs that
completely ceased proliferation and stained strongly for SA-
β-gal, prelamin A, and also showed increased 53BP1 foci
(Figures 1a–g and Supplementary Figures 1 and 2).2
Immunofluorescence microscopy (IF) revealed that prese-
nescent and senescent VSMCs contained increased numbers
of PML NBs per nuclei compared with proliferative VSMCs
(Figures 2a and b, and Supplementary Figure 2). Further
analysis revealed that presenescent VSMCs contained larger
PML NBs than their proliferative and senescent counterparts,
suggesting PML NBs are remodelled during VSMC ageing
(Figures 2a–c and Supplementary Figure 2). Nesprin-2
co-localised with PML NBs (Figure 2a), and in a small
subpopulation of VSMCs, both PML and nesprin-2 decorated
the nucleoli and formed nucleolar cap-like structures (Figures
2a and d), with the frequency of this nucleolar localisation
significantly increased in presenescent and senescent
cultures (Figures 2a and d). ERK localisation also differed
between proliferative, presenescent and senescent VSMCs.
In proliferative cells, ERK2 nuclear staining was diffuse and
co-localisation with nesprin-2 at PML NBs was weak. In
contrast, presenescent cells displayed strong nesprin-2 and
ERK2 co-localisation at PMLNBs that decorated the nucleolar
periphery (Figures 3a–c and Supplementary Figure 3).
Senescent VSMC PML NBs retained their association with
nesprin-2, but ERK2 staining was diffuse with reduced
co-localisation at PML NBs (Figures 3a and b, and
Supplementary Figure 3) suggesting the ERK/nesprin-2/
PML complex was specific to presenescent VSMCs. Immuno-
precipitation (IP) confirmed increased interactions between
total ERK2, active ERK1/2 and nesprin-2 in presenescent
VSMCs compared with proliferative VSMCs (Figures 3d and e)
Moreover, ERK2 precipitated nesprin-2βΔKASH1 (75 kDa)
variant and two larger previously identified NE nesprin-2
variants, whereas pERK1/2 antibodies predominantly preci-
pitated the nesprin-2βΔKASH1 (75 kDa) variant (Figures 3d
and g, and Supplementary Figure 4). Importantly, ERK2 and
pERK1/2 failed to precipitate nesprin-2βΔKASH1 or the larger
nesprin-2 variants from senescent VSMCs, further suggesting
that ERK2 is lost from the complex (Supplementary Figure 5).
The stabilization of the complex in presenescent VSMCs
suggested that it may have a role in DNA damage signalling.
Western blot (WB) confirmed increased levels of γH2AX in
presenescent VSMCs (Supplementary Figure 6). Co-localisation
with γH2AX foci (marking double strand DNA breaks) revealed
that PML-associated ERK2 abutted the sites of DSBs as
shown by the close juxtaposition of nesprin-2 and ERK2
(Supplementary Figure 6).
Lamins A/C are essential for nesprin-2/ERK compart-
mentalisation at PML NBs. To investigate whether an intact
nuclear lamina was necessary for complex formation, lamin
A/C was depleted from VSMCs using siRNA (Figure 4a).
Although the number of PML NBs per nuclei remained
unaltered, they were larger in lamin A/C-depleted VSMCs
compared with control (Figures 4b–d). Moreover, lamin
A/C-depleted cells showed reduced nesprin-2 and ERK2
localisation at PML NBs (Figures 4e and f). To determine the
long-term impact of lamin A/C depletion on VSMC prolifera-
tion, cells were subjected to three rounds of siRNA-mediated
knockdown. Extended lamin A depletion had no effect on
53BP1 foci number per nuclei, PDT or SA-β-gal staining
(Supplementary Figure 7). GST-pull down assays using a
construct containing the C-terminal portion of lamin-A, which
consists of an immunoglobulin domain-like region precipi-
tated nesprin-2βΔKASH1, ERK2 and PML, and this was not
observed with GST alone (Figure 4g), suggesting the
complex could bind directly to lamin A. Several other
nesprin-2 variants were also efficiently precipitated as
expected, including nesprin-2ε2 and p156KASHnesp2
(Figure 4g and Supplementary Figure 4).
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Prelamin A-induced DNA damage triggers ERK1/2 com-
partmentalisation at DNA lesions. Next, we investigated
whether nuclear lamina disruption induced by prelamin A was
the triggering event for ERK1/2 compartmentalisation at PML
NBs. SiRNA-mediated knockdown of the lamin A processing
the enzyme FACE1 to induce prelamin A accumulation in
proliferative VSMCs (Supplementary Figure 8) triggered
an increase in cells with ERK2 localisation at PML NBs
(Figures 5a and b). No nucleolar cap formation was
observed; however, ERK2-associated PML NBs did redis-
tribute toward the nucleolar periphery in FACE1-depleted
cells (Figures 5a and b). As prelamin A accumulation
promotes DNA damage, we also investigated whether DNA
damage per se could induce complex formation. Treatment of
proliferative VSMCs with the DNA damage inducer doxor-
ubicin increased the levels of phosphorylated ERK1/2 in
VSMC lysates (Supplementary Figure 9), and the association
between nesprin-2βΔTM and both ERK2 and phosphorylated
ERK1/2 was also enhanced (Figures 5c and d, and
Supplementary Figure 9). Subcellular fractionation and WB
showed that prelamin A also accumulated in the nuclear
fraction in response to doxorubicin (Supplementary Figure 9)
Prelamin ADAPI merged
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Figure 1 Characterisation of VSMC ageing. (a) VSMCs grown in vitro display three distinct growth phases we termed proliferative (PDT 2–5 days), presenescence (PDT 6–
8 days) and senescence. Graph shows the combined growth curve data from three independent experiments. (b) Cells from each phase stained for SA-β-gal activity; graph
shows the combined data of three independent experiments (*P= 0.0033). (c) IF images of prelamin A accumulation (red) and DAPI (blue). (d) Quantification of prelamin A
accumulation in presenescent (*P= 0.0051) and senescent (**P= 0.0001) VSMCs. (e) WB of prelamin A and FACE1 levels in proliferative and presenescent VSMCs. (f) IF
images of 53BP1 (green), a marker of persistent DNA damage signalling, and DAPI (blue). (g) Quantification of cells displaying 53BP1 foci in presenescent (*P= 0.0263) and
senescent (**P= 0.0328) cells. Graphs represent the combined data from three independent experiments counting 300 cells per condition
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suggesting there is a potential feedback between ERK
compartmentalisation and prelamin A accumulation in
response to DNA damage.
Confocal immunofluorescence showed that doxorubicin
treatment caused a dose-dependent, relocalisation of both
nesprin-2 and PML into nucleolar cap structures (Figures 5e
and f, and Supplementary Figure 9). After a short-term
treatment with doxorubicin (1 h), ERK2 was lacking in these
nucleolar caps (Figures 5e and f). However, prolonged
doxorubicin (3 h) treatment enhanced the association of
ERK2 with the nesprin-2-positive nucleolar caps (Figures 5e
and f). Pretreatment with the MEK inhibitor U0126 failed to
disrupt nesprin-2 reorganisation into the nucleolar cap, but it
dramatically reduced ERK2 association with the nucleolar cap
suggesting that active ERK1/2 are components of this
complex (Figures 5e and f).
Complex formation is essential for ATM signalling fidelity
and its disruption leads to genomic instability. ERK1/2
enhance ATM/ATR-mediated signalling during DNA repair, so
we next examined the effect of releasing ERK1/2 from the
complex in presenescent VSMCs by depleting nesprin-2.
SiRNA knockdown was confirmed by qRT-PCR and WB
(Figures 6a–c), and IF confirmed the loss of nesprin-2 from
PML NBs (Figure 6d). WB analysis showed that complex
disruption induced the DNA damage shown by increased
γH2AX staining by WB and flow cytometry (Figures 6c and e).
Comet assays confirmed the presence of unrepaired DNA
damage shown by significantly increased comet tail intensity
in nesprin-2-depleted cells. In contrast, increased DNA
damage was not observed in PML-depleted VSMCs, suggest-
ing that nesprin-2 is the key ERK scaffold in the complex
(Figures 6f and g, and Supplementary Figure 10).
**
*
***
*
**
***
*
**
Nesprin-2 PML MergedDAPI
Proliferative
Presenescent 8µm
Figure 2 PML NB reorganisation during VSMC ageing. (a) IF images of nesprin-2 and PML NBs in proliferative and presenescent VSMCs; DAPI (blue), nesprin-2 (green) and
PML (red). Arrowheads mark nucleolar caps. Circle marks nucleoli position. Quantification of (b) average number of PML NBs per nucleus (*P= 0.0339, **P= 0.01,
***P= 0.001); (c) average PML NB size (*P=o0.001, **P=o0.001, ***P=o0.001); and (d) number of cells displaying nucleolar caps (*P= 0.0116 and **P= 0.0076) in
proliferative, presenescent and senescent phases of growth. Graphs show the combined data of three independent experiments counting 300 cells
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Next, we sought to determine the signalling pathways
within the DDR that regulate ERK compartmentalisation.
Depletion of the DDR kinase ATM in VSMCs blocked the
dynamic reorganisation of nesprin-2 and PML into nucleolar
caps in response to DNA damage (Supplementary Figure
11) suggesting a link between ERK and ATM signalling. To
investigate this further, nesprin-2 and lamin A/C-depleted
cells were treated with doxorubicin. Doxorubicin treatment
stimulated the ATM activity (marked by ser1981 phosphor-
ylation) in control VSMCs, and this response was also
observed in nesprin-2 and lamin A/C-depleted VSMCs
(Figures 7a and b). However, analysis of the downstream
ATM target Chk2 revealed that Chk2 phosphorylation in
response to DNA damage was significantly impaired
in nesprin-2-depleted, but not lamin A/C-depleted,
VSMCs, although lamin A/C-depleted lysates displayed a
modest, nonsignificant reduction in Chk2 phosphorylation
(Figures 7a and c). Control nuclei displayed multiple
ATM foci in response to DNA damage (62.67± 2.082;
Figures 7d and e), whereas nesprin-2 or lamins A/C
depletion blocked the induction of ATM foci in response to
DNA damage (19.67± 10.69 and 21.67± 9.609, respec-
tively; Figures 7d and e) suggesting ERK compartmentalisa-
tion during the DDR is also essential for maintaining ATM
localisation and activation of downstream ATM targets in the
presence of DNA damage.
In addition to their role in regulating DNA repair, ATM/ATR
also activate cell cycle checkpoints. Nesprin-2-depleted
VSMCs displayed a fourfold increase in cells with
mitotic defects, such as telophase bridges and lagging
chromosomes (Figures 7f and g), as well as a
twofold increase in cells displaying micronuclei (Figures
7h and i) indicative of G2/M checkpoint failure and genomic
instability.
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Figure 3 Increased nesprin-2/ERK1/2 compartmentalisation at PML NBs during VSMC ageing. (a) IF showing the localisation of nesprin-2 (green) and ERK2 (red) in
proliferative, presenescent and senescent VSMCs. Arrows mark nucleolar caps. Quantification of (b) cells displaying nesprin-2 (*P= 0.0114 and **P= 0.0004) and ERK2
(***P= 0.0117) localisation at PML NBs; and (c) proliferative and presenescent VSMCs displaying ERK2-positive nucleolar caps (*P= 0.0008). Graphs show the combined data
of three independent experiments counting 300 cells. IPs showing the association between (d) ERK2 and (f) pERK1/2 with nesprin-2 in proliferative and presenescent VSMCs.
Graphs show the combined data of three independent experiments performing densitometry measurement of precipitated/start ratio for each nesprin variant precipitated by (e)
ERK2 (*P= 0.025, **P= 0.0226, ***P= 0.0004) and (g) pERK1/2 (*P= 0.0458)
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Discussion
Prelamin A accumulation promotes ERK compartmenta-
lisation and VSMC senescence. In this study, we show that
VSMC ageing in vitro is characterized by three distinct growth
phases: rapid proliferation in young cells is followed by a
presenescent phase characterised by a slowing of cell growth
and the accumulation of prelamin A, which is then rapidly
followed by growth arrest and cellular senescence. Prelamin
A accumulation in presenescent VSMCs was associated with
increased DNA damage and also with increased compart-
mentalisation of ERK1/2 at PML NBs, suggesting that signals
associated with prelamin A accumulation and/or DNA
damage may induce complex formation.2,7 The consistent
accumulation of prelamin A in presenescent VSMCs sug-
gests that prelamin A may have unique functions in the DDR
in VSMCs. We speculate that prelamin A may be part of a
feedback mechanism to block VSMC proliferation, as low
levels were associated with nuclear reorganization of
signalling complexes, which promoted cell cycle delay and
DNA repair. However, when DNA damage persists, prelamin
A accumulates further and can interfere with DNA damage
repair ultimately leading to robust cellular senescence2,3
as observed in VSMCs and Zmpste24/FACE1-deficient
fibroblasts.19 Prelamin A accumulation in proliferative VSMCs
or SMCs derived from HGPS iPS cells has also been shown
to lead to mitotic failure.20 This cellular outcome is likely to
further accelerate senescence and may contribute to the
rapid induction of senescence following prelamin A accumu-
lation. Clearly, further elucidation of the factors that regulate
prelamin A accumulation in VSMCs during the DDR and
VSMC ageing are now required.
Lamin A associates with nesprin-2, ERK and PML.
Lamins A/C form a filamentous network throughout the
nucleus that spatially organises DNA-repair and nuclear
signalling events.6 We speculated that lamins A/C were good
candidates to spatially regulate the nesprin-2/ERK/PML
*
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Figure 4 The A-type lamins are essential for nesprin-2/ERK/PML complex organisation in VSMCs. (a) WB of control and lamin A-depleted VSMC lysates. (b) IF showing
PML organisation (green) and DAPI (blue) in control and lamin A-depleted VSMCs; Quantification of (c) PML size (*P=o0.0001) and (d) PML number per nuclei in control and
lamin A-depleted VSMCs. Graphs show the combined data of three independent experiments counting 300 cells. (e) IF showing nesprin-2 (green) and ERK2 (red) localisations in
control and lamin A-depleted nuclei. (f) Quantification of nesprin-2 localisation at PML NBs in control and lamin A-depleted VSMC nuclei (***P= 0.0009). Graph shows the
combined data of three independent experiments counting 300 cells. (g) WB of GST-pull downs using bacterial expressed lamin A tail construct and VSMC lysates
Nesprin-2 regulates ERK activity during DNA repair
DT Warren et al
1545
Cell Death and Differentiation
complex, and we confirmed that this complex interacts with
the C-terminus of lamin A. Nesprin-2 and ERK1/2 have
previously been shown to independently interact with lamin A;
nesprin-2 binds to the lamin A tail via its SRs, whereas
ERK1/2 bind to coil 2 of lamin A, suggesting that nesprin-
2βΔKASH1 also couples ERK1/2 to the lamin A tail,
independently of the coil 2/ERK interaction.21–23 Moreover,
lamins A/C disruption resulted in increased PML NB size in
VSMCs, and this is consistent with the larger PML NBs with
reduced mobility observed in lamin A-deficient nuclei.18
Changes in PML size were also observed in VSMCs with
prelamin A accumulation; however, whether these larger
bodies have different functionality has not been determined.
Lamins A/C disruption also resulted in disruption of ERK
compartmentalisation, suggesting that lamins A/C perform a
scaffolding role anchoring the nesprin-2/ERK complex at
PML NBs during the DDR. However, despite the involvement
of lamins A/C in nesprin-2/ERK compartmentalisation, lamins
A/C depletion did not impair, ATM or Chk2 phosphorylation
and DNA damage continued to be efficiently repaired. This
suggests that lamins A/C and ERK compartmentalisation are
not essential for DNA repair and that nesprin-2/ERK
maintains signalling integrity even when diffusely localised
in the nucleoplasm.
Efficient DNA repair does not require PML NBs in
VSMCs. Although PML NBs have been implicated in DNA
repair, their importance remains controversial.13,24 Numerous
DNA-repair proteins, including ATM and ATR, are known to
localise at PML NBs in the absence of DNA damage.25–27
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Figure 5 Prelamin A accumulation induces ERK1/2 compartmentalisation at PML NBs that abut DNA lesions. (a) IF showing nesprin-2 (green) and ERK2 (red) localisations
in control and FACE1-depleted nuclei. Arrows mark PML NBs localised towards the nucleolar periphery. (b) Quantification of ERK2 localisation at PML NBs (*P= 0.0278) and
nucleolar periphery (**P= 0.0202) in control and FACE1-depleted nuclei. Graph shows the combined data of three independent experiments counting 300 cells. IP of (c) ERK2
antibody to pellet 75 kDa nesprin-2βΔKASH1 variant and (d) nesprin-2 antibody to pellet ERK2 from control and doxorubicin-treated VSMCs. (e) IF of doxorubicin-treated
proliferative VSMCs; nesprin-2 (green), ERK2 (red). Arrowheads mark nucleolar caps. (f) Quantification of cells displaying ERK2-positive nucleolar caps after a 3-h doxorubicin
treatment (*P= 0.0081 and **P= 0.0146). Graph shows the combined data of three independent experiments counting 300 cells
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Genotoxic stress increases the PML NB number, stimulates
their association at DNA lesions and induces the loss of
these repair proteins from PML NBs.25–27 Post-translational
modification is proposed to play a role in the relocalisation of
these proteins raising the intriguing possibility that ERK1/2
recruitment to PML NBs may stimulate the redistribution of
repair proteins. In addition, PML NBs may serve to store
active ERK1/2 during the DDR, and further investigation is
required to clarify the relationship between PML NBs and
ERK1/2 signalling in the nucleus. DNA damage also
stimulated organisation of PML-associated ERK1/2 into
nucleolar caps. The function of these nucleolar caps within
the DDR has yet to be fully elucidated, although PML has
been shown to influence p53 activity by sequestering
MDM2 at the nucleolus.14,15,28 Thus, nucleolar caps may
serve as hubs to regulate the cell cycle during the DDR.
However, despite these connections between PML NBs and
DNA repair, we show that PML disruption did not ablate DNA
repair in VSMCs (Supplementary Figure 5). This observation is
consistent with a previous study demonstrating that PML NBs are
nonessential for DNA repair and senescence in fibroblasts.29
Importantly, depletion of lamins A/C or PML disrupted ERK2
compartmentalisation, suggesting that both serve as scaffolds to
assist lesion repair. However, disrupted ERK compartmentalisa-
tion, either by lamins A/C or PML depletion, failed to ablate DNA
repair, further suggesting that nesprin-2βΔKASH1 remains
associated with ERK1/2 and signalling fidelity remains intact
even when compartmentalisation is lost.
Nesprin-2βΔKASH1 is essential for efficient DNA repair
and cell cycle delay. In contrast to lamins A/C and PML,
nesprin-2βΔKASH1 was essential for efficient DNA repair in
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Figure 6 Disruption of nesprin-2 increases basal levels of DNA damage. (a) Schematic representation of the siRNA oligomer positions targeting nesprin-2βΔTM. (b) qPCR
confirmed efficient knockdown of the nesprin-2βΔTM 5’UTR using two independent strategies; a single siRNA (siRNA 1) or a pool of siRNA (siRNA 2). Graph shows the
combined data of three independent experiments repeated in triplicate (*P= 0.0028 and ***P= 0.0038, respectively). (c) WB analysis of control and nesprin-2-depleted VSMCs.
(d) IF showing nesprin-2 (green) and PML (red) localisations in control and nesprin-2-depleted VSMCs. (e) FAC analysis of control and nesprin-2-depleted cells displaying γH2AX
staining. (f) IF of comet assay after control and nesprin-2 depletion. (g) Quantification of comet assays (*P= 0.0005). Graph represents the combined data from three
independent experiments
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VSMCs. We have previously shown that nesprin-2βΔKASH1
depletion stimulated VSMC proliferation, suggesting that this
complex may regulate cell cycle progression and in support
of this notion, nesprin-2 depleted VSMCs displayed mitotic
defects and micronuclei formation, indicative of a G2/M
checkpoint defect.10,16 Although previous studies have
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implicated ERK1/2 in regulating cell cycle progression in
response to DNA damage,16,30 for the first time we implicate
nesprin-2 in the G2/M checkpoint. The failure of nesprin-2
depleted cells to block mitotic entry may be twofold; due to a
failure of ERK1/2 to phosphorylate target proteins that are
required to activate G2/M arrest and/or due to the activation
of inappropriate ERK target proteins that promote cell cycle
progression. However, despite the existence of a large body
of evidence implicating ERK1/2 in DNA repair and the DDR,
our knowledge of the proteins ERK1/2 target during this
process is lacking, although ATM/ATR are possible candi-
dates as they also regulate activation of cell cycle check-
points in response to DNA damage.
Nesprin-2βΔKASH1 is comprised of two sets of double SRs
separated by a flexible unstructured linker region and although our
knowledge of nesprin-2βΔKASH1-binding partners remains lim-
ited, we have previously shown that phosphorylated ERK1/2 can
bind to the N-terminal SRs of nesprin-2βΔKASH1.10,31,32 An
intriguing possibility is that nesprin-2βΔKASH1 may also interact
with ERK1/2 target proteins involved in DNA repair. Owing to the
flexibility between the N-terminal and C-terminal SR modules,
nesprin-2βΔKASH1 may enhance the phosphorylation of ERK1/2
targets bybringing substrates into closeproximitywithERK1/2.31,32
Indeed, other ERK1/2 scaffold proteins, such as MEK-partner-1
and kinase suppressor of RAS, are known to interact with several
components of the RAS/RAF/MEK/ERK pathway to enhance
signalling.33–35 Further studies focused on identifying novel
nesprin-2βΔKASH1-binding partners, particularly those involved
in DNA repair, are required to delineate the precise roles of both
nesprin-2βΔKASH1 and ERK1/2 in the DNA-repair process.
Materials and Methods
Cell culture. Human aortic VSMCs from four different male and female donors
ranging in age from 20 to 54 years were cultured as described previously, and
characterised for proliferation capacity and senescence. For all studies, excluding
those requiring serial passaging to presenescence and senescence, VSMCs in the
proliferative phase (P6–P9) were used.36 Nesprin-2 siRNA oligomers targeting the
nesprin-2βΔKASH1 variant have been described previously.10 PDTwas determined
using the online calculator at www.doubling-time.com/compute.php. VSMCs were
plated at a known density and counts were performed on each passage until
senescence. ATM, ATR, FACE1 and lamin-A smart pool siRNA oligomers from
Dharmacon (Lafayette, CO, USA) were used in this study. Transfection of siRNA
was performed using Hyperfect (Qiagen, Venlo, Netherlands), as per the
manufacturer’s instructions. Cells were treated with 0.5 μM Doxorubicin (Sigma,
St. Louis, MO, USA) for the indicated time to induce DNA damage. ATM/ATR and
ERK1/2 inhibition was achieved by incubating cells overnight in the presence of
5 μM CGK733 (Sigma) or for the time stated with 20 μM U0126 (Cell Signaling
Technologies, Danvers, MA, USA), respectively.
Antibodies, IF and flow cytometry. Antibodies used for WB, IF and IPs
were the following: ATM (ab78), ATR (ab2905), nucleolin (ab13541; Abcam,
Cambridge, UK); pH2AX (#9718), pSer15 p53, pSer1981 ATM (#5883), 53BP1
(#4937), pChk2 (T68) (#2661), Chk2 (#6334; Cell Signaling Technologies); Face-1
C-13 (sc-34777), prelamin-A C-20 (sc-6214), lamin A/C N-18 (sc-6215), PML PG-
M3 (sc-966), ERK2 D-2 (sc-1647), pERK1/2 E-4 (sc-7383; Santa Cruz, Dallas, TX,
USA); Vinculin (V9131), β-actin (A5316; Sigma); and nesprin-2 N3. Secondary
antibodies for WB were horseradish peroxidase-conjugated antimouse (NA931) or
antirabbit (NA94V) antibodies from GE Healthcare (Lafayette, CO, USA). ECL
chemiluminescent kit (RPN2132, GE Healthcare) was used for the detection
according to the manufacturer’s instructions. Invitrogen (Paisley, UK) Anti-Mouse
Alexa Fluor 568 (A11031) and Anti-Rabbit Alexa Fluor 488 (A11034, Invitrogen)
were used as IF secondary antibodies. Cells were cultured on cover slips, fixed in
50% methanol/acetone and processed as described previously. SA-β-gal staining
was performed as described previously.2 For observing the DNA content of cells by
propidium iodide staining, cells were trypsinised and washed three times in PBS.
Cells were fixed in ice-cold 75% ethanol for 30 min at 4 °C. DNA staining was
achieved by addition of PI and RNase for 45 min at 37 °C. For γH2AX staining cells
were processed as per the manufacturer’s instructions (Cell Signaling
Technologies).
Confocal microscopy and data analysis. All images were captured at
× 63 magnification using a Leica (Milton Keynes, UK) SP5 laser scanning confocal
microscope. PML number and size was measured using the find object function in
the Volocity software (PerkinElmer, Waltham, MA, USA).
IPs and subcellular fractionations. In vivo IPs, GST-pull downs and
subcellular fractionations were performed as described previously.10
Comet assays. DNA damage was assessed using the Comet assays as
described previously.2 Protocols were obtained from the Comet Assay Interest
Group website (www.cometassay.com).
Statistics. The results are presented as mean± S.E.M. For the comparison of
proliferative/presenescent/senescent groups, unpaired Student’s t-tests were
performed. For siRNA knockdown groups, paired Student’s t-tests were performed.
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